Skip to main content
. 2011 Jul 20;55:10.3402/fnr.v55i0.5961. doi: 10.3402/fnr.v55i0.5961

Table 4.

Fasting plasma or serum concentrations of blood parameters, HOMA-R and HOMA-β in week 0 and week 10, and changes between week 0 and week 10 of the intervention1

Week 0 Week 10 Change2
Glucose (mmol/l) Sucrose 4.68±0.11 4.92±0.12 0.24±0.09
Sweetener 4.78±0.08 4.87±0.13 0.09±0.15
Insulin (pmol/l) Sucrose 41.8±5.3 53.6±7.9 11.8±4.93
Sweetener 37.0±5.3 35.8±4.8 –1.2±3.2
Lactate (mmol/l) Sucrose 1.09±0.14 1.11±0.13 0.02±0.08
Sweetener 0.83±0.05 0.89±0.12 0.06±0.10
NEFA (µmol/l) Sucrose 595±44 532±35 –63±33
Sweetener 535±53 524±69 –10±80
TAG (mmol/l) Sucrose 1.48±0.18 1.75±0.243 0.27±0.12
Sweetener 1.07±0.12 1.01±0.14 –0.05±0.17
Total cholesterol (mmol/l) Sucrose 5.20±0.30 5.07±0.29 –0.13±0.19
Sweetener 5.28±0.32 5.26±0.36 –0.02±0.17
HDL-cholesterol (mmol/l) Sucrose 1.31±0.06 1.34±0.07 0.03±0.06
Sweetener 1.47±0.12 1.47±0.13 0.00±0.05
Glucagon (pmol/l) Sucrose 3.2±0.4 4.0±0.5 0.8±0.4
Sweetener 2.9±0.4 3.2±0.4 0.4±0.6
GIP (pmol/l) Sucrose 8.8±2.2 9.8±1.73 1.0±2.03
Sweetener 7.6±1.9 5.1±1.3 –2.5±2.2
GLP-1 (pmol/l) Sucrose 13.3±0.95 13.8±0.75 0.4±0.5
Sweetener 8.0±0.6 9.4±0.7 1.4±0.8
Leptin (ng/ml) Sucrose 19.8±2.2 26.9±2.24 7.1±1.74
Sweetener 16.1±3.4 15.1±2.5 –1.0±2.1
HOMA-R Sucrose 1.46±0.20 1.96±0.29 0.50±0.18
Sweetener 1.32±0.21 1.32±0.2 0.00±0.15
HOMA-β Sucrose 26.0±3.6 32.9±5.5 6.9±3.5
Sweetener 22.1±3.4 20.7±3.0 –1.4±1.8
1

Mean±SEM. N=12 in the sucrose group and n=11 in sweetener group. Sucrose: sucrose group, Sweetener: sweetener group, NEFA: non-esterified fatty acids, TAG: triacylglycerol, GIP: glucose-dependent insulinotropic polypeptide, GLP-1: glucagon-like peptide-1.

2

Change is calculated as week 10 minus week 0. An ANOVA was performed with week 0 value as covariate.

3–5

Significant difference between sucrose and sweetener groups (ANOVA). 3P<0.05, 4P<0.01, 5P<0.001.